44 related articles for article (PubMed ID: 19800606)
1. High visceral fat percentage is associated with poor outcome in endometrial cancer.
Mauland KK; Eng Ø; Ytre-Hauge S; Tangen IL; Berg A; Salvesen HB; Salvesen ØO; Krakstad C; Trovik J; Hoivik EA; Werner HMJ; Mellgren G; Haldorsen IS
Oncotarget; 2017 Dec; 8(62):105184-105195. PubMed ID: 29285243
[TBL] [Abstract][Full Text] [Related]
2. The effect of first chromosome long arm duplication on survival of endometrial carcinoma.
Sever E; Doğer E; Çakıroğlu Y; Sünnetçi D; Çine N; Savlı H; Yücesoy İ
Turk J Obstet Gynecol; 2014 Dec; 11(4):207-210. PubMed ID: 28913021
[TBL] [Abstract][Full Text] [Related]
3. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
[TBL] [Abstract][Full Text] [Related]
4. The significance of markers in the diagnosis of endometrial cancer.
Żyła MM; Wilczyński JR; Kostrzewa M; Księżakowska-Łakoma K; Nowak M; Stachowiak G; Szyłło K; Stetkiewicz T
Prz Menopauzalny; 2016 Nov; 15(3):176-185. PubMed ID: 27980530
[TBL] [Abstract][Full Text] [Related]
5. What Is the Best Preoperative Imaging for Endometrial Cancer?
Haldorsen IS; Salvesen HB
Curr Oncol Rep; 2016 Apr; 18(4):25. PubMed ID: 26922331
[TBL] [Abstract][Full Text] [Related]
6. Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.
Danielsen HE; Pradhan M; Novelli M
Nat Rev Clin Oncol; 2016 May; 13(5):291-304. PubMed ID: 26598944
[TBL] [Abstract][Full Text] [Related]
7. Genetic Instability and Disease Prognostication.
Gemoll T; Auer G; Ried T; Habermann JK
Recent Results Cancer Res; 2015; 200():81-94. PubMed ID: 26376873
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.
Njølstad TS; Trovik J; Hveem TS; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; ; Amant F; Werner HM; Salvesen HB; Danielsen HE
Br J Cancer; 2015 May; 112(10):1656-64. PubMed ID: 25897678
[TBL] [Abstract][Full Text] [Related]
9. Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer.
Povolotskaya N; Das N; Dhar K; Brinkmann D; Gardner F; Woolas R
Surg Res Pract; 2014; 2014():497478. PubMed ID: 25379556
[TBL] [Abstract][Full Text] [Related]
10. Current status of molecular biomarkers in endometrial cancer.
Werner HM; Salvesen HB
Curr Oncol Rep; 2014 Sep; 16(9):403. PubMed ID: 25064587
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer.
Bilbao-Sieyro C; Ramírez R; Rodríguez-González G; Falcón O; León L; Torres S; Fernández L; Alonso S; Díaz-Chico N; Perucho M; Díaz-Chico JC
Oncotarget; 2014 Aug; 5(15):6206-17. PubMed ID: 25026289
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium.
Pradhan M; Abeler VM; Danielsen HE; Sandstad B; Tropé CG; Kristensen GB; Risberg BÅ
Ann Oncol; 2012 May; 23(5):1178-1184. PubMed ID: 21965471
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapeutic targets in endometrial cancer.
Dedes KJ; Wetterskog D; Ashworth A; Kaye SB; Reis-Filho JS
Nat Rev Clin Oncol; 2011 May; 8(5):261-71. PubMed ID: 21221135
[TBL] [Abstract][Full Text] [Related]
15. Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting.
Wik E; Trovik J; Iversen OE; Engelsen IB; Stefansson IM; Vestrheim LC; Haugland HK; Akslen LA; Salvesen HB
Am J Obstet Gynecol; 2009 Dec; 201(6):603.e1-7. PubMed ID: 19800606
[TBL] [Abstract][Full Text] [Related]
16. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
17. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
18. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of DNA content assessment in endometrial cancer.
Mauland KK; Wik E; Salvesen HB
Cytometry B Clin Cytom; 2014 May; 86(3):154-63. PubMed ID: 24532190
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
